Cited 0 times in
Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정현철 | - |
dc.date.accessioned | 2023-06-02T00:53:54Z | - |
dc.date.available | 2023-06-02T00:53:54Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194505 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | American Society of Clinical Oncology | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinoma | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Kohei Shitara | - |
dc.contributor.googleauthor | Yung-Jue Bang | - |
dc.contributor.googleauthor | Satoru Iwasa | - |
dc.contributor.googleauthor | Naotoshi Sugimoto | - |
dc.contributor.googleauthor | Min-Hee Ryu | - |
dc.contributor.googleauthor | Daisuke Sakai | - |
dc.contributor.googleauthor | Hyun Cheol Chung | - |
dc.contributor.googleauthor | Yasushi Omuro | - |
dc.contributor.googleauthor | Hisato Kawakami | - |
dc.contributor.googleauthor | Hiroshi Yabusaki | - |
dc.contributor.googleauthor | Yasuhiro Sakamoto | - |
dc.contributor.googleauthor | Tomohiro Nishina | - |
dc.contributor.googleauthor | Koichiro Inaki | - |
dc.contributor.googleauthor | Yusuke Kuwahara | - |
dc.contributor.googleauthor | Fumitaka Suto | - |
dc.contributor.googleauthor | Masahiro Sugihara | - |
dc.contributor.googleauthor | Kaku Saito | - |
dc.contributor.googleauthor | Akihito Kojima | - |
dc.contributor.googleauthor | Kensei Yamaguchi | - |
dc.identifier.doi | 10.1200/JCO.2022.40.4_suppl.322 | - |
dc.contributor.localId | A03773 | - |
dc.relation.journalcode | J01331 | - |
dc.identifier.eissn | 1527-7755 | - |
dc.identifier.url | https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.322 | - |
dc.contributor.alternativeName | Chung, Hyun Cheol | - |
dc.contributor.affiliatedAuthor | 정현철 | - |
dc.citation.volume | 40 | - |
dc.citation.number | 4 Suppl | - |
dc.citation.startPage | 322 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 Suppl) : 322, 2022-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.